Hester Biosciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 524669 |
NSE Symbol : HESTERBIO |
P/E(TTM) : 69.31 |
ISIN Demat : INE782E01017 |
Div & Yield% : 0.25 |
EPS(TTM) : 34.23 |
Book Value(₹) : 367.60 |
Market Cap(₹Cr) : 2,018.13 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 73.47 | 72.87 | 65.51 | 66.43 | 80.35 | 60.70 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 73.47 | 72.87 | 65.51 | 66.43 | 80.35 | 60.70 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 1.06 | 1.20 | 0.98 | 1.22 | 0.86 | 0.95 |
Total Income | 74.52 | 74.08 | 66.49 | 67.65 | 81.20 | 61.65 |
Total Expenditure | 59.97 | 60.46 | 53.94 | 54.44 | 68.98 | 49.78 |
PBIDT | 14.55 | 13.62 | 12.55 | 13.21 | 12.22 | 11.87 |
Interest | 1.13 | 1.31 | 1.37 | 1.48 | 0.94 | 0.35 |
PBDT | 13.43 | 12.31 | 11.18 | 11.74 | 11.28 | 11.52 |
Depreciation | 2.12 | 2.08 | 2.57 | 2.58 | 2.55 | 2.62 |
Tax | 2.87 | 3.28 | 1.51 | 2.48 | 2.37 | 2.29 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | -0.48 | 0.63 | -0.11 | -0.10 | 0.35 |
Reported Profit After Tax | 8.43 | 7.43 | 6.48 | 6.78 | 6.47 | 6.26 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 8.43 | 7.43 | 6.48 | 6.78 | 6.47 | 6.26 |
EPS (Unit Curr.) | 9.91 | 8.74 | 7.61 | 7.97 | 7.61 | 7.36 |
EPS (Adj) (Unit Curr.) | 9.91 | 8.74 | 7.61 | 7.97 | 7.61 | 7.36 |
Calculated EPS (Unit Curr.) | 9.91 | 8.74 | 7.61 | 7.97 | 7.61 | 7.36 |
Calculated EPS (Adj) (Unit Curr.) | 9.91 | 8.74 | 7.61 | 7.97 | 7.61 | 7.36 |
Calculated EPS (Ann.) (Unit Curr.) | 39.65 | 34.94 | 30.45 | 31.89 | 30.43 | 29.45 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 39.65 | 34.94 | 30.45 | 31.89 | 30.43 | 29.45 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 19.80 | 18.69 | 19.16 | 19.89 | 15.21 | 19.56 |
PBDTM(%) | 18.28 | 16.89 | 17.07 | 17.67 | 14.04 | 18.98 |
PATM(%) | 11.47 | 10.20 | 9.89 | 10.21 | 8.05 | 10.31 |